Alexander Baras

Assistant Professor

19992018
If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 3 Similar Profiles
Urinary Bladder Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Cisplatin Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Cystectomy Medicine & Life Sciences
Carcinoma Medicine & Life Sciences
Muscles Medicine & Life Sciences
MicroRNAs Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1999 2018

  • 60 Article
  • 1 Conference contribution
  • 1 Review article

Implications of the tumor immune microenvironment for staging and therapeutics

Taube, J. M., Galon, J., Sholl, L. M., Rodig, S. J., Cottrell, T. R., Giraldo, N. A., Baras, A. S., Patel, S. S., Anders, R. A., Rimm, D. L. & Cimino-Mathews, A. Feb 1 2018 In : Modern Pathology. 31, 2, p. 214-234 21 p.

Research output: Contribution to journalReview article

Tumor Microenvironment
Neoplasms
Biomarkers
Therapeutics
Th1 Cells

Neoadjuvant Dose Dense MVAC versus Gemcitabine and Cisplatin in Patients with cT3-4aN0M0 Bladder Cancer Treated with Radical Cystectomy

Collaborators Jun 1 2018 In : Journal of Urology. 199, 6, p. 1452-1458 7 p.

Research output: Contribution to journalArticle

gemcitabine
Vinblastine
Cystectomy
Urinary Bladder Neoplasms
Methotrexate

Prostaglandin receptors induce urothelial tumourigenesis as well as bladder cancer progression and cisplatin resistance presumably via modulating PTEN expression

Kashiwagi, E., Inoue, S., Mizushima, T., Chen, J., Ide, H., Kawahara, T., Reis, L. O., Baras, A. S., Netto, G. J. & Miyamoto, H. Jan 1 2018 In : British Journal of Cancer. 118, 2, p. 213-223 11 p.

Research output: Contribution to journalArticle

Prostaglandin Receptors
Celecoxib
Phosphoric Monoester Hydrolases
Urinary Bladder Neoplasms
Cisplatin
Lung Neoplasms
Carcinoma
Neoplasms
Investigational Therapies
DNA Sequence Analysis

A phase II trial of dovitinib in BCG-unresponsive urothelial carcinoma with FGFR3 mutations or overexpression: Hoosier Cancer Research Network trial HCRN 12-157

Hahn, N. M. , Bivalacqua, T. J. , Ross, A. E. , Netto, G. J. , Baras, A. , Park, J. C. , Chapman, C. , Masterson, T. A. , Koch, M. O. , Bihrle, R. , Foster, R. S. , Gardner, T. A. , Cheng, L. , Jones, D. R. , McElyea, K. , Sandusky, G. E. , Breen, T. , Liu, Z. , Albany, C. , Moore, M. L. & 9 others Loman, R. L., Reed, A., Turner, S. A., De Abreu, F. B., Gallagher, T., Tsongalis, G. J., Plimack, E. R., Greenberg, R. E. & Geynisman, D. M. Jun 15 2017 In : Clinical Cancer Research. 23, 12, p. 3003-3011 9 p.

Research output: Contribution to journalArticle

Mycobacterium bovis
Carcinoma
Mutation
Research
Neoplasms